239 related articles for article (PubMed ID: 12451119)
1. Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.
Kim J; Isokawa M; Ledent C; Alger BE
J Neurosci; 2002 Dec; 22(23):10182-91. PubMed ID: 12451119
[TBL] [Abstract][Full Text] [Related]
2. Cholecystokinin inhibits endocannabinoid-sensitive hippocampal IPSPs and stimulates others.
Karson MA; Whittington KC; Alger BE
Neuropharmacology; 2008 Jan; 54(1):117-28. PubMed ID: 17689570
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.
Nallapaneni A; Liu J; Karanth S; Pope C
Neurotoxicology; 2008 Nov; 29(6):1037-43. PubMed ID: 18765251
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic Acetylcholine M
Wolfe CIC; Hwang EK; Ijomor EC; Zapata A; Hoffman AF; Lupica CR
J Neurosci; 2022 Jul; 42(28):5552-5563. PubMed ID: 35764382
[TBL] [Abstract][Full Text] [Related]
5. Endocannabinoid-mediated control of synaptic transmission.
Kano M; Ohno-Shosaku T; Hashimotodani Y; Uchigashima M; Watanabe M
Physiol Rev; 2009 Jan; 89(1):309-80. PubMed ID: 19126760
[TBL] [Abstract][Full Text] [Related]
6. Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain.
Bisogno T; Howell F; Williams G; Minassi A; Cascio MG; Ligresti A; Matias I; Schiano-Moriello A; Paul P; Williams EJ; Gangadharan U; Hobbs C; Di Marzo V; Doherty P
J Cell Biol; 2003 Nov; 163(3):463-8. PubMed ID: 14610053
[TBL] [Abstract][Full Text] [Related]
7. Role of endogenous cannabinoids in synaptic signaling.
Freund TF; Katona I; Piomelli D
Physiol Rev; 2003 Jul; 83(3):1017-66. PubMed ID: 12843414
[TBL] [Abstract][Full Text] [Related]
8. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
[TBL] [Abstract][Full Text] [Related]
9. Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
Devane WA; Hanus L; Breuer A; Pertwee RG; Stevenson LA; Griffin G; Gibson D; Mandelbaum A; Etinger A; Mechoulam R
Science; 1992 Dec; 258(5090):1946-9. PubMed ID: 1470919
[TBL] [Abstract][Full Text] [Related]
10. Developmental neurotoxicity of the organophosphorus insecticide chlorpyrifos: from clinical findings to preclinical models and potential mechanisms.
Burke RD; Todd SW; Lumsden E; Mullins RJ; Mamczarz J; Fawcett WP; Gullapalli RP; Randall WR; Pereira EFR; Albuquerque EX
J Neurochem; 2017 Aug; 142 Suppl 2(Suppl 2):162-177. PubMed ID: 28791702
[TBL] [Abstract][Full Text] [Related]
11. Relationships of human α/β hydrolase fold proteins and other organophosphate-interacting proteins.
Lenfant N; Bourne Y; Marchot P; Chatonnet A
Chem Biol Interact; 2016 Nov; 259(Pt B):343-351. PubMed ID: 27109753
[TBL] [Abstract][Full Text] [Related]
12. Cholinergic Neurotransmission Controls Orexigenic Endocannabinoid Signaling in the Gut in Diet-Induced Obesity.
Wood CP; Alvarez C; DiPatrizio NV
J Neurosci; 2024 May; 44(20):. PubMed ID: 38594069
[TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid 2-Arachidonoylglycerol Synthesis and Metabolism at Neuronal Nuclear Matrix Fractions Derived from Adult Rat Brain Cortex.
Aretxabala X; García Del Caño G; Barrondo S; López de Jesús M; González-Burguera I; Saumell-Esnaola M; Goicolea MA; Sallés J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834575
[TBL] [Abstract][Full Text] [Related]
14. Differential Regulation of Prelimbic and Thalamic Transmission to the Basolateral Amygdala by Acetylcholine Receptors.
Tryon SC; Bratsch-Prince JX; Warren JW; Jones GC; McDonald AJ; Mott DD
J Neurosci; 2023 Feb; 43(5):722-735. PubMed ID: 36535767
[TBL] [Abstract][Full Text] [Related]
15. 2-AG-Mediated Control of GABAergic Signaling Is Impaired in a Model of Epilepsy.
Colangeli R; Morena M; Werner A; Thompson RJ; van der Stelt M; Pittman QJ; Hill MN; Teskey GC
J Neurosci; 2023 Jan; 43(4):571-583. PubMed ID: 36460464
[TBL] [Abstract][Full Text] [Related]
16. Endocannabinoids at the synapse and beyond: implications for neuropsychiatric disease pathophysiology and treatment.
Scheyer A; Yasmin F; Naskar S; Patel S
Neuropsychopharmacology; 2023 Jan; 48(1):37-53. PubMed ID: 36100658
[TBL] [Abstract][Full Text] [Related]
17. Effector membrane translocation biosensors reveal G protein and βarrestin coupling profiles of 100 therapeutically relevant GPCRs.
Avet C; Mancini A; Breton B; Le Gouill C; Hauser AS; Normand C; Kobayashi H; Gross F; Hogue M; Lukasheva V; St-Onge S; Carrier M; Héroux M; Morissette S; Fauman EB; Fortin JP; Schann S; Leroy X; Gloriam DE; Bouvier M
Elife; 2022 Mar; 11():. PubMed ID: 35302493
[TBL] [Abstract][Full Text] [Related]
18. 2-Arachidonoylglycerol mobilization following brief synaptic stimulation in the dorsal lateral striatum requires glutamatergic and cholinergic neurotransmission.
Liput DJ; Puhl HL; Dong A; He K; Li Y; Lovinger DM
Neuropharmacology; 2022 Mar; 205():108916. PubMed ID: 34896118
[TBL] [Abstract][Full Text] [Related]
19. Effects of prenatal ethanol exposure on choline-induced long-term depression in the hippocampus.
Grafe EL; Fontaine CJ; Thomas JD; Christie BR
J Neurophysiol; 2021 Nov; 126(5):1622-1634. PubMed ID: 34495785
[TBL] [Abstract][Full Text] [Related]
20. Cannabinoids Regulate Sensory Processing in Early Olfactory and Visual Neural Circuits.
Heinbockel T; Straiker A
Front Neural Circuits; 2021; 15():662349. PubMed ID: 34305536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
